In this study, we first performed whole exome sequencing of DNA from 10 untreated and
clinically annotated fresh frozen nasopharyngeal carcinoma (NPC) biopsies and matched …

Nasopharyngeal carcinoma (NPC) has extremely skewed ethnic and geographic
distributions, is poorly understood at the genetic level and is in need of effective therapeutic …

Oncogene mutations contribute to carcinogenesis and can provide potential therapeutic
targets for clinical anticancer management. However, oncogene mutation patterns in …

Nasopharyngeal carcinoma (NPC), also named the Cantonese cancer, is a unique cancer
with strong etiological association with infection of the Epstein-Barr virus (EBV). With …

Nasopharyngeal carcinoma (NPC) is a malignant head and neck cancer type with high
morbidity in Southeast Asia, however the pathogenic mechanism of this disease is poorly …

BACKGROUND To date, no targeted therapy has been approved for nasopharyngeal
carcinoma (NPC), and this underscores the need for an in‐depth understanding of clinically …

The aim of this study was to use whole‐exome sequencing to derive a molecular classifier
for nasopharyngeal carcinoma (NPC) and evaluate its clinical performance. We performed …

Background Nasopharyngeal carcinoma (NPC) is one of the most common cancers. To
investigate the gene mutation profile of NPC patients, we performed whole exome …

Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer characterized by
Epstein-Barr virus (EBV) infection and dense lymphocyte infiltration. The scarcity of NPC …

Nasopharyngeal carcinoma (NPC) is a common tumor in Southern China, but the oncogene
mutational status of NPC patients has not been clarified. Using time-of-flight mass …